<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Dynamic Homeostatic Failure Theory of Alzheimer's Disease - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Theory Details for theory-2357</h1>

        <div class="section">
            <h2>Theory (General Information)</h2>
            <div class="info-section">
                <p><strong>ID:</strong> theory-2357</p>
                <p><strong>Name:</strong> Dynamic Homeostatic Failure Theory of Alzheimer's Disease</p>
                <p><strong>Type:</strong> general</p>
                <p><strong>Theory Query:</strong> Build a theory of the causes of Alzheimer's disease and effective detection methods.</p>
                <p><strong>Description:</strong> This theory proposes that Alzheimer's disease results from a progressive failure of the brain's homeostatic mechanisms to maintain synaptic, proteostatic, and metabolic balance in the face of age-related and environmental stressors. The breakdown of these adaptive systems leads to the accumulation of pathological proteins, synaptic dysfunction, and ultimately neurodegeneration. Detection should focus on early markers of homeostatic stress and compensatory failure, such as synaptic activity changes, proteostasis network collapse, and metabolic inflexibility.</p>
                <p><strong>Knowledge Cutoff Year:</strong> -1</p>
                <p><strong>Knowledge Cutoff Month:</strong> -1</p>
                <p><strong>Base Model:</strong> openai/gpt-4.1-2025-04-14</p>
            </div>
        </div>

        <div class="section">
            <h2>Theory (Derived From)</h2>
            <p><strong>Derived From:</strong> <span class="empty-note">None</span></p>
            <p><strong>Change Log:</strong> <span class="empty-note">No change log entries.</span></p>
        </div>

        <div class="section">
            <h2>Evaluations of this Theory</h2>
            <p class="empty-note">No evaluations of this theory.</p>
        </div>

        <div class="section">
            <h2>Theory (Details)</h2>

            <h3>Theory Statements</h3>
            <h3>Statement 0: Homeostatic Collapse Law (qualitative)</h3>
<table>
<thead> 
<tr><th style="width: 10%;">Condition</th><th style="width: 90%;">Details</th></tr>
</thead>
<tbody>
<tr>
    <td><strong>IF</strong></td>
    <td>
        <div>&#8226; brain &#8594; experiences &#8594; chronic stressors (aging, inflammation, metabolic stress)<span style="color: #888888;">, and</span></div>
        <div>&#8226; homeostatic systems &#8594; fail to compensate &#8594; increased proteostatic, synaptic, or metabolic load</div>
    </td>
</tr>
<tr>
    <td><strong>THEN</strong></td>
    <td>
        <div>&#8226; brain &#8594; accumulates &#8594; misfolded proteins (amyloid, tau), synaptic loss, and metabolic dysfunction<span style="color: #888888;">, and</span></div>
        <div>&#8226; individual &#8594; develops &#8594; Alzheimer's disease</div>
    </td>
</tr>
</tbody>
</table>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>Proteostasis network impairment (e.g., reduced autophagy, chaperone function) precedes amyloid and tau accumulation. </li>
    <li>Synaptic dysfunction and loss are early events in AD and correlate with cognitive decline. </li>
    <li>Aging and chronic inflammation reduce the brain's ability to clear misfolded proteins. </li>
    <li>Metabolic inflexibility (e.g., impaired glucose utilization) is observed before overt neurodegeneration. </li>
</ol>            <h4>Existing Law Comparison</h4>
            <p><strong>Likely Classification:</strong> <span style="color: orange; font-weight: bold;">somewhat-related-to-existing</span></p>
            <p><strong>Explanation:</strong> While elements exist in the literature, the explicit framing of AD as a dynamic homeostatic failure is a novel synthesis.</p>            <p><strong>What Already Exists:</strong> Proteostasis and synaptic failure are recognized as contributors to AD, and homeostatic mechanisms are studied in neurodegeneration.</p>            <p><strong>What is Novel:</strong> This law unifies these failures as a primary, dynamic process, emphasizing the progressive collapse of adaptive systems as the root cause.</p>
            <p><strong>References:</strong> <ul>
    <li>Selkoe (2002) Alzheimer's disease is a synaptic failure [Synaptic dysfunction]</li>
    <li>Morimoto & Cuervo (2014) Proteostasis and aging: new insights into the etiology of neurodegeneration [Proteostasis failure]</li>
    <li>Mattson (2004) Pathways towards and away from Alzheimer's disease [Homeostatic adaptation]</li>
</ul>
            <h3>Statement 1: Early Homeostatic Stress Detection Law (qualitative)</h3>
<table>
<thead> 
<tr><th style="width: 10%;">Condition</th><th style="width: 90%;">Details</th></tr>
</thead>
<tbody>
<tr>
    <td><strong>IF</strong></td>
    <td>
        <div>&#8226; detection_method &#8594; measures &#8594; early markers of synaptic, proteostatic, or metabolic stress</div>
    </td>
</tr>
<tr>
    <td><strong>THEN</strong></td>
    <td>
        <div>&#8226; detection_method &#8594; enables &#8594; preclinical identification of individuals at risk for AD</div>
    </td>
</tr>
</tbody>
</table>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>Synaptic activity markers (e.g., SV2A PET, EEG slowing) change before clinical symptoms. </li>
    <li>Proteostasis stress markers (e.g., unfolded protein response, chaperone levels) are altered in at-risk individuals. </li>
    <li>Metabolic imaging (e.g., FDG-PET) detects hypometabolism years before diagnosis. </li>
</ol>            <h4>Existing Law Comparison</h4>
            <p><strong>Likely Classification:</strong> closely-related-to-existing</p>
            <p><strong>Explanation:</strong> The focus on homeostatic stress as the earliest and most reliable detection target is a novel extension.</p>            <p><strong>What Already Exists:</strong> Early detection using synaptic and metabolic markers is under investigation.</p>            <p><strong>What is Novel:</strong> This law asserts that homeostatic stress markers are the most sensitive and specific for preclinical AD risk.</p>
            <p><strong>References:</strong> <ul>
    <li>Chen et al. (2018) Imaging synaptic density in Alzheimer disease with SV2A PET [Synaptic marker]</li>
    <li>Mosconi et al. (2008) FDG-PET in the early diagnosis of Alzheimer's disease [Metabolic marker]</li>
    <li>Hetz & Saxena (2017) ER stress and the unfolded protein response in neurodegeneration [Proteostasis marker]</li>
</ul>
            <h3>New Predictions (Likely outcome)</h3>
            <ol>
                <li>Individuals with early evidence of synaptic or proteostatic stress will have a higher risk of developing AD, even in the absence of amyloid or tau pathology.</li>
                <li>Interventions that enhance homeostatic capacity (e.g., boosting autophagy, synaptic plasticity) will delay or prevent AD onset.</li>
            </ol>
            <h3>New Predictions (Unknown outcome/high-entropy)</h3>
            <ol>
                <li>Novel blood-based markers of proteostasis stress will predict AD risk before any imaging or cognitive changes.</li>
                <li>Restoring homeostatic function in aged brains will reverse early AD pathology.</li>
            </ol>
            <h3>Negative Experiments</h3>
            <ol>
                <li>If individuals with robust homeostatic markers still develop AD at the same rate as those with impaired markers, the theory is challenged.</li>
                <li>If amyloid/tau pathology develops in the absence of any detectable homeostatic stress, the theory is called into question.</li>
            </ol>
            <h3>Unaccounted for Evidence</h3>
<ol>
    <li>Familial AD due to deterministic mutations may bypass homeostatic failure and directly induce pathology. </li>
</ol>            <h3>Existing Theory Comparison</h3>
            <p><strong>Likely Classification:</strong> somewhat-related-to-existing</p>
            <p><strong>Explanation:</strong> This theory synthesizes existing elements into a new, dynamic systems framework for AD causation and detection.</p>
            <p><strong>References:</strong> <ul>
    <li>Selkoe (2002) Alzheimer's disease is a synaptic failure [Synaptic dysfunction]</li>
    <li>Morimoto & Cuervo (2014) Proteostasis and aging: new insights into the etiology of neurodegeneration [Proteostasis failure]</li>
    <li>Mattson (2004) Pathways towards and away from Alzheimer's disease [Homeostatic adaptation]</li>
</ul>
        </div>

        <div class="section">
            <h2>Theory Components (Debug)</h2>
            <pre><code>{
    "theory_name": "Dynamic Homeostatic Failure Theory of Alzheimer's Disease",
    "theory_description": "This theory proposes that Alzheimer's disease results from a progressive failure of the brain's homeostatic mechanisms to maintain synaptic, proteostatic, and metabolic balance in the face of age-related and environmental stressors. The breakdown of these adaptive systems leads to the accumulation of pathological proteins, synaptic dysfunction, and ultimately neurodegeneration. Detection should focus on early markers of homeostatic stress and compensatory failure, such as synaptic activity changes, proteostasis network collapse, and metabolic inflexibility.",
    "theory_statements": [
        {
            "law": {
                "law_name": "Homeostatic Collapse Law",
                "if": [
                    {
                        "subject": "brain",
                        "relation": "experiences",
                        "object": "chronic stressors (aging, inflammation, metabolic stress)"
                    },
                    {
                        "subject": "homeostatic systems",
                        "relation": "fail to compensate",
                        "object": "increased proteostatic, synaptic, or metabolic load"
                    }
                ],
                "then": [
                    {
                        "subject": "brain",
                        "relation": "accumulates",
                        "object": "misfolded proteins (amyloid, tau), synaptic loss, and metabolic dysfunction"
                    },
                    {
                        "subject": "individual",
                        "relation": "develops",
                        "object": "Alzheimer's disease"
                    }
                ],
                "supporting_evidence": [
                    {
                        "text": "Proteostasis network impairment (e.g., reduced autophagy, chaperone function) precedes amyloid and tau accumulation.",
                        "uuids": []
                    },
                    {
                        "text": "Synaptic dysfunction and loss are early events in AD and correlate with cognitive decline.",
                        "uuids": []
                    },
                    {
                        "text": "Aging and chronic inflammation reduce the brain's ability to clear misfolded proteins.",
                        "uuids": []
                    },
                    {
                        "text": "Metabolic inflexibility (e.g., impaired glucose utilization) is observed before overt neurodegeneration.",
                        "uuids": []
                    }
                ],
                "qual_or_quant": "qualitative",
                "existing_law": {
                    "what_already_exists": "Proteostasis and synaptic failure are recognized as contributors to AD, and homeostatic mechanisms are studied in neurodegeneration.",
                    "what_is_novel": "This law unifies these failures as a primary, dynamic process, emphasizing the progressive collapse of adaptive systems as the root cause.",
                    "classification_explanation": "While elements exist in the literature, the explicit framing of AD as a dynamic homeostatic failure is a novel synthesis.",
                    "likely_classification": "somewhat-related-to-existing",
                    "references": [
                        "Selkoe (2002) Alzheimer's disease is a synaptic failure [Synaptic dysfunction]",
                        "Morimoto & Cuervo (2014) Proteostasis and aging: new insights into the etiology of neurodegeneration [Proteostasis failure]",
                        "Mattson (2004) Pathways towards and away from Alzheimer's disease [Homeostatic adaptation]"
                    ]
                }
            }
        },
        {
            "law": {
                "law_name": "Early Homeostatic Stress Detection Law",
                "if": [
                    {
                        "subject": "detection_method",
                        "relation": "measures",
                        "object": "early markers of synaptic, proteostatic, or metabolic stress"
                    }
                ],
                "then": [
                    {
                        "subject": "detection_method",
                        "relation": "enables",
                        "object": "preclinical identification of individuals at risk for AD"
                    }
                ],
                "supporting_evidence": [
                    {
                        "text": "Synaptic activity markers (e.g., SV2A PET, EEG slowing) change before clinical symptoms.",
                        "uuids": []
                    },
                    {
                        "text": "Proteostasis stress markers (e.g., unfolded protein response, chaperone levels) are altered in at-risk individuals.",
                        "uuids": []
                    },
                    {
                        "text": "Metabolic imaging (e.g., FDG-PET) detects hypometabolism years before diagnosis.",
                        "uuids": []
                    }
                ],
                "qual_or_quant": "qualitative",
                "existing_law": {
                    "what_already_exists": "Early detection using synaptic and metabolic markers is under investigation.",
                    "what_is_novel": "This law asserts that homeostatic stress markers are the most sensitive and specific for preclinical AD risk.",
                    "classification_explanation": "The focus on homeostatic stress as the earliest and most reliable detection target is a novel extension.",
                    "likely_classification": "closely-related-to-existing",
                    "references": [
                        "Chen et al. (2018) Imaging synaptic density in Alzheimer disease with SV2A PET [Synaptic marker]",
                        "Mosconi et al. (2008) FDG-PET in the early diagnosis of Alzheimer's disease [Metabolic marker]",
                        "Hetz & Saxena (2017) ER stress and the unfolded protein response in neurodegeneration [Proteostasis marker]"
                    ]
                }
            }
        }
    ],
    "new_predictions_likely": [
        "Individuals with early evidence of synaptic or proteostatic stress will have a higher risk of developing AD, even in the absence of amyloid or tau pathology.",
        "Interventions that enhance homeostatic capacity (e.g., boosting autophagy, synaptic plasticity) will delay or prevent AD onset."
    ],
    "new_predictions_unknown": [
        "Novel blood-based markers of proteostasis stress will predict AD risk before any imaging or cognitive changes.",
        "Restoring homeostatic function in aged brains will reverse early AD pathology."
    ],
    "negative_experiments": [
        "If individuals with robust homeostatic markers still develop AD at the same rate as those with impaired markers, the theory is challenged.",
        "If amyloid/tau pathology develops in the absence of any detectable homeostatic stress, the theory is called into question."
    ],
    "unaccounted_for": [
        {
            "text": "Familial AD due to deterministic mutations may bypass homeostatic failure and directly induce pathology.",
            "uuids": []
        }
    ],
    "conflicting_evidence": [
        {
            "text": "Some individuals with significant homeostatic stress markers do not progress to AD.",
            "uuids": []
        }
    ],
    "special_cases": [
        "Genetic resilience factors may preserve homeostatic function despite stress.",
        "Rapid-onset AD in rare cases may not follow a gradual homeostatic collapse."
    ],
    "existing_theory": {
        "what_already_exists": "Proteostasis, synaptic, and metabolic failure are recognized in AD, and homeostatic adaptation is a known concept.",
        "what_is_novel": "The dynamic, unified framing of AD as a progressive homeostatic collapse, and the prioritization of homeostatic stress markers for detection, is novel.",
        "classification_explanation": "This theory synthesizes existing elements into a new, dynamic systems framework for AD causation and detection.",
        "likely_classification": "somewhat-related-to-existing",
        "references": [
            "Selkoe (2002) Alzheimer's disease is a synaptic failure [Synaptic dysfunction]",
            "Morimoto & Cuervo (2014) Proteostasis and aging: new insights into the etiology of neurodegeneration [Proteostasis failure]",
            "Mattson (2004) Pathways towards and away from Alzheimer's disease [Homeostatic adaptation]"
        ]
    },
    "reflected_from_theory_index": 0,
    "type": "general",
    "version": "built-theory-from-results-single-theory-reflection2-nov14-2025-LLM-BASELINE-no-evidence-without-matched-control-theory-name",
    "theory_query": "Build a theory of the causes of Alzheimer's disease and effective detection methods.",
    "original_theory_id": "theory-683",
    "original_theory_name": "Peripheral Platelet Tau/AÎ² Signature as a Surrogate for Central Neurodegeneration",
    "provide_matched_control_thery_name": false,
    "matched_control_theory_name": null,
    "model_str": "openai/gpt-4.1-2025-04-14"
}</code></pre>
        </div>
    </div>
</body>
</html>